low-molecular-weight heparin

(redirected from LMWH)
Also found in: Thesaurus, Medical, Acronyms, Encyclopedia.
Related to LMWH: Fondaparinux

low-molecular-weight heparin

n.
Mentioned in ?
References in periodicals archive ?
Enoxaparin (Clexane[R], Rhone-Poulenc Rorer) was the only LMWH prescribed for patients in this study.
Partsch (2001) evaluated 1,289 consecutive patients hospitalized from 1992 to 1998 with a diagnosis of acute symptomatic DVT of the lower extremities to estimate precisely the short-term complications of DVT, including pulmonary embolism at admission, incidence of new PE after 10 days, bleeding, heparin-induced thrombocytopenia, and fatalities in a population treated with ambulation, compression, and LMWH.
A careful balancing of risks and balances is warranted in such cases, and might result in a decision to continue warfarin until the end of pregnancy or to use LMWH at high doses with careful monitoring, Dr.
LMWH levels cannot be monitored by the aPTT, but require a specialised anti-Xa assay, which is currently available at Johannesburg Hospital Haematology Laboratory (tel (011) 488-3068).
Neither LMWH nor unfractionated heparin crosses the placenta, and neither is associated with embryopathy or fetal bleeding," they wrote.
Hokusai-VTE CANCER is the first study to demonstrate that a DOAC, edoxaban, is non-inferior to the standard of care, injectable LMWH (dalteparin), in this population.
Our case report is the first one with LMWH as extended anticoagulant therapy in a patient with IVC duplication and extensive DVT.
13] We explored the effects of LMWH (subcutaneous enoxaparin) in our settings.
Other anticoagulant medications such as LMWH and fondaparinux (Arixtra[R]) can increase antiXa levels.
Extended duration LMWH for at least six months is currently the standard of care for treatment of acute DVT and pulmonary embolism in active cancer patients.
In terms of safety, it was no contest: The NOACs were collectively associated with a 39% lower risk of major bleeding, a 64% lower risk of fatal bleeding, and a 63% reduction in intracranial bleeding compared to LMWH /warfarin (Blood.